microneedle patch glp 1 Single-Administration Self-Boosting for The Treatment of Obesity Patch Minceur à Micro-aiguilles Patch

(2023) 46:S128S39

From the doseinhibition curves obtained in vitro we can estimate that this equates to a GLP-1(936) concentration of 30 pmol/l, in remarkably good agreement with the plasma GLP-1 concentration observed in vivo

These medications can lead to a significant and clinically meaningful reduction in body weight when used in conjunction with lifestyle changes

[DOI] [PMC free article] [PubMed] [Google Scholar] [38].Singh P, Youden B, Yang Y, Chen Y, Carrier A, Cui S, Oakes K, Servos M, Jiang R, Zhang X, Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites, ACS Applied Materials & Interfaces 13(35) (2021) 4146441472

But progress was slow and not much happened before Knudsen went on maternity leave (Gilbert, Rosenthal, March 2024)

Ozempic was originally developed to lower blood sugar in patients with type 2 diabetes